Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.
about
Antioxidant protection from HIV-1 gp120-induced neuroglial toxicityFocal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice.Innate Immune Response in Brain, NF-Kappa B Signaling and CystatinsNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaNeuroinflammation in Alzheimer's diseaseRegulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disordersTriptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's diseaseThe Alzheimer pandemic: is paracetamol to blame?Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex.Regional age-related changes in neuronal nitric oxide synthase (nNOS), messenger RNA levels and activity in SAMP8 brain.Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemiaDexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia.Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.Microglia in neurodegeneration: molecular aspects.Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Neuroprotective strategies involving ROS in Alzheimer disease.Oxidative stress and nitration in neurodegeneration: cause, effect, or association?Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias.Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerizationThiazolidinediones: novel treatments for cognitive deficits in mood disorders?Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's DiseaseThe effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.Activated astrocytes: a therapeutic target in Alzheimer's disease?Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity.Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology.Vitamin D as a potential therapy in amyotrophic lateral sclerosis.The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.Innate immune activation in neurodegenerative disease.Truncated and modified amyloid-beta species.Innate immunity in Alzheimer's disease.Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update.Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
P2860
Q24794513-3AFCE8C8-0F87-450C-A906-593EB51FFEFCQ24812365-E7ACFA38-A1C7-49FD-A5A2-E8084A02FF84Q26773162-02C4B23C-0E40-424E-926E-076505AE8B53Q28070156-702F9BD8-72FF-4DCE-B1DB-0CF213E2A793Q28075617-5BA8941D-01DB-443C-B88E-79A171B1017FQ28259238-182DDBDA-0027-40DD-B765-76890AB9E493Q28386313-576B9A5A-39D1-4726-A4B1-11BDBB094F13Q28543501-6E282CF3-40CC-4BCE-94D4-743E07DB0804Q30357019-9E06E4E3-75F7-41E2-82FA-BBF0D5C81A92Q33201804-70F6E932-F5AD-429F-B605-B6C38EBA6D68Q33267384-3359BAD0-7275-489E-8FDC-B00CBCF27022Q33567203-50F7A388-7758-4D65-9962-1F81CFDA1C57Q33913000-083E5355-0311-4D44-A7CA-1149E0C5916CQ33922669-3CBC78B3-2E57-4367-84BA-D44DCB2E2B64Q34349294-0BAB1A22-0EC0-4282-83D6-55FD768C950BQ34391616-3087C8D8-6592-4F37-8751-04C24799F2A2Q34757939-FB92FD81-5E2D-4989-A3D8-28FD3BCC865CQ35047296-03FCE080-C552-4DAC-A816-D77FA73E7760Q35088324-1B0CCB7F-3E0C-4727-B7AC-7C7AC2A4AF70Q35841723-38CB7B23-C6F3-449D-8095-EC6B2AC0C7AFQ36329164-5B5BF1F7-2E22-455B-A2D1-1B40A3C92A56Q36377165-5C9BF15E-7459-463D-90C2-D2AA1DD09CF1Q36403694-A5348573-552B-4B36-BD2D-62EF9D8978BCQ36501810-DD012704-94B7-4011-8069-B9D385CF7714Q36904879-FF3EDCEE-52E4-4484-9FF7-4EF35477BD80Q37163288-ECAD1EDA-985E-496E-86F6-477B6ED90C5CQ37240480-7E770899-4099-45B5-A88A-28FD562D926BQ37261981-7C0BDEA4-56F2-407A-AD56-732508A4484BQ37354744-3F327F3B-22BE-4CCE-8938-6515BE7683E2Q37380089-C31D612E-F015-4784-A675-75037AAE6441Q37630535-1B55B92D-434A-4000-AB0E-D8DCB2576747Q37837951-43A90B24-6430-4B95-A6C7-F54B6FC67B35Q38126949-9F684E5C-A5F8-4681-A861-BDE6315D40FBQ38178758-6B82B0BB-6CDC-4B5E-B6A1-EF7EAEF9081FQ38198015-9A02AFED-E2C0-47CE-A953-D8AE9C497074Q38223011-8EEBC4F5-7D49-47EC-B6C1-EFFF5E6CF8CEQ38230390-0A645D9E-073E-41D7-A55B-6F3DF1B494DDQ38358574-969D31D3-A868-4BDD-AE29-AA7455B374F8Q38558744-FE83A3DB-1D3B-4DDA-8DD4-EDF5400432A7Q38770352-8BA3D744-80FD-40A3-AC20-88D5A2CC1606
P2860
Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@ast
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@en
type
label
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@ast
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@en
prefLabel
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@ast
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Inducible nitric oxide synthas ...... ents with Alzheimer's disease.
@en
P2093
Flanders KC
Roberts AB
Vodovotz Y
P2860
P304
P356
10.1084/JEM.184.4.1425
P407
P577
1996-10-01T00:00:00Z